Cellular mechanism of immune dysfunction following burn injury
烧伤后免疫功能障碍的细胞机制
基本信息
- 批准号:7799750
- 负责人:
- 金额:$ 30.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-06 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnti-Inflammatory AgentsAnti-inflammatoryBindingBurn injuryCD8B1 geneCause of DeathCell DeathCellsDendritic CellsEffectivenessExhibitsFamilyFamily memberHumanImmuneImmune System DiseasesImmune ToleranceImmune responseImmune systemImmunologicsImmunotherapeutic agentImpairmentInfectionInflammatoryInjuryMediatingMediator of activation proteinMolecularMultiple Organ FailureMusNucleotidesOrgan failurePatientsPatternPhasePredispositionProcessProductionPseudomonas aeruginosaReceptor SignalingRelative (related person)RestRoleSecondary toSepsisSignal PathwaySignal TransductionSkin TransplantationSkin graftT cell responseT-LymphocyteT-Lymphocyte SubsetsTestingToll-like receptorsUp-Regulationallograft rejectionclinically relevantcytokinedesignimmune functionin vivomacrophagemicrobialnovel therapeuticspreventpublic health relevancereceptorreceptor expressionresearch studyresponseskin allograftwound
项目摘要
DESCRIPTION (provided by applicant): The leading causes of death following serious burn injury are sepsis and multiple system organ failure secondary to profound innate and adaptive immune dysfunction, though the controlling mechanism for the response is unknown. Major determinants of immune activity are the innate Toll-like receptor (TLR) and nucleotide binding oligomerization domain (NOD)-like receptor (NLR) families. These are expressed by many immune cells and their primary function is to sense microbial molecules leading to cytokine release or cell death. Our overall hypothesis is that impairment of both the innate and adaptive immune systems after burn injury is mediated directly by TLR and NLR signaling. The proposed experiments are designed to test this hypothesis during both immunopathogenic phases after burn injury and investigate innate receptor-blockade as a possible immunotherapeutic approach for clinically relevant issues facing burn patients. First, to determine the mechanism by which TLR and NLR signaling controls the innate immune system after injury: We will determine phenotypic and functional (cytokine and cell death) changes of MF and DC using an animal model of burn injury. We will correlate TLR and NLR expression with changes in their function during early and late after burn injury. We will then use TLR and NLR deficient mice to validate that the altered burn injury-mediated innate immune response is mediated through innate-receptor signaling. Second, to determine the mechanism by which innate signaling controls the adaptive immune response after burn injury: We will examine the effect of burn injury on the expression and activation of TLR and NLR on CD4+ and CD8+ T cells and relevant T cell subsets. We will correlate changes in TLR and NLR expression with the ability of T cells to elicit an adaptive immune response. To determine the relative importance of both direct (expression of innate receptors on T cells) and indirect (expression on MF or DC) innate receptor expression in mediating the adaptive response to burn injury, we will transfer T cells or MF and DC, deficient in innate signaling receptors, into burn or sham recipients and test T cell immune function and survival. Third, to demonstrate that innate receptors are critical for the dysfunctional immunologic response to burn injury in vivo: We will use mice deficient in TLR and NLR innate signaling to examine the role of innate receptors in mediating skin allograft rejection and preventing establishment of effective immune tolerance after burn. We will examine the importance of innate signaling pathways in mediating Pseudomonas aeruginosa susceptibility early and late after burn injury using mice deficient in TLR and NLR signaling. PUBLIC HEALTH RELEVANCE: The leading causes of death following serious burn injury are uncontrolled infection and organ failure. These are due to profound problems with the patient's immune system. We propose to determine the cellular and molecular mechanisms underlying these immune problems.
描述(由申请人提供):严重烧伤后死亡的主要原因是败血症和继发于严重先天性和适应性免疫功能障碍的多系统器官衰竭,尽管该反应的控制机制尚不清楚。免疫活性的主要决定因素是先天性Toll样受体(TLR)和核苷酸结合寡聚化结构域(NOD)样受体(NLR)家族。这些由许多免疫细胞表达,其主要功能是感知微生物分子,导致细胞因子释放或细胞死亡。我们的总体假设是,烧伤后先天性和适应性免疫系统的损害是由TLR和NLR信号直接介导的。所提出的实验旨在测试这一假设在烧伤后的两个免疫病理阶段,并调查先天受体阻断作为一种可能的免疫治疗方法,烧伤患者面临的临床相关问题。首先,为了确定TLR和NLR信号传导在损伤后控制先天免疫系统的机制:我们将使用烧伤动物模型确定MF和DC的表型和功能(细胞因子和细胞死亡)变化。我们将TLR和NLR的表达与烧伤后早期和晚期的功能变化相关联。然后,我们将使用TLR和NLR缺陷小鼠来验证改变的烧伤介导的先天免疫应答是通过先天受体信号传导介导的。第二,确定先天性信号传导控制烧伤后适应性免疫应答的机制:我们将检测烧伤对CD4+和CD8+ T细胞及其相关T细胞亚群上TLR和NLR表达和活化的影响。我们将TLR和NLR表达的变化与T细胞引发适应性免疫应答的能力相关联。为了确定直接(T细胞上先天受体的表达)和间接(MF或DC上的表达)先天受体表达在介导对烧伤的适应性反应中的相对重要性,我们将先天信号传导受体缺陷的T细胞或MF和DC转移到烧伤或假受体中,并测试T细胞免疫功能和存活。第三,为了证明先天性受体在体内对烧伤损伤的功能失调的免疫反应中是至关重要的:我们将使用TLR和NLR先天性信号传导缺陷的小鼠来研究先天性受体在介导皮肤同种异体移植排斥反应和防止烧伤后建立有效的免疫耐受中的作用。我们将使用TLR和NLR信号缺陷的小鼠研究先天信号通路在介导烧伤后早期和晚期铜绿假单胞菌易感性中的重要性。公共卫生相关性:严重烧伤后死亡的主要原因是不受控制的感染和器官衰竭。这是由于患者免疫系统的严重问题。我们建议确定这些免疫问题的细胞和分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce A Cairns其他文献
Bruce A Cairns的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce A Cairns', 18)}}的其他基金
Multi-modal rescue of pulmonary NRF2-insufficiency after burn and burn + inhalation injury to regulate innate immune dysfunction
烧伤及烧伤吸入性损伤后肺NRF2不足的多模式抢救调节先天免疫功能障碍
- 批准号:
10435748 - 财政年份:2022
- 资助金额:
$ 30.04万 - 项目类别:
Multi-modal rescue of pulmonary NRF2-insufficiency after burn and burn + inhalation injury to regulate innate immune dysfunction
烧伤及烧伤吸入性损伤后肺NRF2不足的多模式抢救调节先天免疫功能障碍
- 批准号:
10732822 - 财政年份:2022
- 资助金额:
$ 30.04万 - 项目类别:
Multi-modal rescue of pulmonary NRF2-insufficiency after burn and burn + inhalation injury to regulate innate immune dysfunction
烧伤及烧伤吸入性损伤后肺NRF2不足的多模式抢救调节先天免疫功能障碍
- 批准号:
10651857 - 财政年份:2022
- 资助金额:
$ 30.04万 - 项目类别:
Damage-Induced Activation of the TLR/mTOR/PPARg Axis Regulates the Immune Response After Burn and Inhalation Injury
损伤诱导的 TLR/mTOR/PPARg 轴激活调节烧伤和吸入性损伤后的免疫反应
- 批准号:
10300052 - 财政年份:2018
- 资助金额:
$ 30.04万 - 项目类别:
Damage-Induced Activation of the TLR/mTOR/PPARg Axis Regulates the Immune Response After Burn and Inhalation Injury
损伤诱导的 TLR/mTOR/PPARg 轴激活调节烧伤和吸入性损伤后的免疫反应
- 批准号:
10062997 - 财政年份:2018
- 资助金额:
$ 30.04万 - 项目类别:
Damage-Induced Activation of the TLR/mTOR/PPARg Axis Regulates the Immune Response After Burn and Inhalation Injury
损伤诱导的 TLR/mTOR/PPARg 轴激活调节烧伤和吸入性损伤后的免疫反应
- 批准号:
10531808 - 财政年份:2018
- 资助金额:
$ 30.04万 - 项目类别:
Role of extraceullar vesicles in directing immunometabolic homeostasis after burn injury
细胞外囊泡在烧伤后指导免疫代谢稳态中的作用
- 批准号:
10337838 - 财政年份:2018
- 资助金额:
$ 30.04万 - 项目类别:
Cellular mechanism of immune dysfunction following burn injury
烧伤后免疫功能障碍的细胞机制
- 批准号:
8445370 - 财政年份:2009
- 资助金额:
$ 30.04万 - 项目类别:
Cellular mechanism of immune dysfunction following burn injury
烧伤后免疫功能障碍的细胞机制
- 批准号:
8244359 - 财政年份:2009
- 资助金额:
$ 30.04万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 30.04万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 30.04万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 30.04万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 30.04万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 30.04万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 30.04万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 30.04万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 30.04万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 30.04万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 30.04万 - 项目类别:














{{item.name}}会员




